Toxicity Studies
Toxicity Studies - Related Videos
09:13
Hydroponics: A Versatile System to Study Nutrient Allocation and Plant Responses to Nutrient Availability and Exposure to Toxic Elements
0 Views •
Cited by 102 •
2016
Here, we present an easy-to-follow protocol to establish a successful hydroponic system for plant nutrition studies. This protocol has been extensively tested in Arabidopsis and can easily be adapted to other plant species to study specific nutritional requirements or the effect of non-essential elements on plant growth and development.
09:06
Growth Assays to Assess Polyglutamine Toxicity in Yeast
0 Views •
Cited by 3 •
2012
This manuscript describes three complementary protocols for assessing the toxicity of polyglutamine (polyQ)-expansion proteins in the yeast Saccharomyces cerevisiae. These protocols can easily be modified to monitor the toxicity of other misfolded proteins in yeast.
08:49
Vegetated Treatment Systems for Removing Contaminants Associated with Surface Water Toxicity in Agriculture and Urban Runoff
0 Views •
Cited by 4 •
2017
This article summarizes the design attributes and the effectiveness of treatment systems that treat urban stormwater and agriculture irrigation runoff to remove pesticides and other contaminants associated with aquatic toxicity.
09:49
Kupffer Cell Isolation for Nanoparticle Toxicity Testing
0 Views •
Cited by 28 •
2015
Liver macrophages, named Kupffer cells, are responsible for the capture of circulating nanoparticles. We describe here a method, of high cell purity and yield, for Kupffer cell isolation. The modified LDH assay is used here to measure the toxicity induced by carbon nanotubes in Kupffer cells.
08:58
Using Caenorhabditis elegans for Studying Trans- and Multi-Generational Effects of Toxicants
0 Views •
Cited by 9 •
2019
Trans- and multi-generational effects of persistent chemicals are essential in judging their long-term consequences in the environment and on the human health. We provide novel detailed methods for studying trans- and multi-generational effects using free-living nematode Caenorhabditis elegans.
FAQs
Dose-response analysis links a substance’s defined concentration or dose to the biological, physiological, or pathological changes observed in a model. Examining this relationship helps researchers identify how increasing exposure alters harmful effects and supports dose optimization. In pharmacology, these patterns help distinguish potentially tolerable exposure levels from conditions associated with adverse drug reactions or injury.
These study types differ mainly in the duration and pattern of exposure. Acute studies examine effects after a short exposure, whereas repeated-dose studies evaluate consequences of administering a substance over multiple periods. Chronic studies extend observation over longer durations, which can reveal effects that emerge gradually, including injury associated with sustained exposure, metabolism, or accumulation.
A substance’s harmful effects may depend not only on its initial exposure but also on how it is processed or retained in the system. Toxicity studies therefore consider risks associated with metabolism and accumulation, because repeated or prolonged exposure can produce effects that are not apparent during a shorter assessment. This information helps clarify potential target-organ injury and adverse drug reactions.
Researchers expose cells, tissues, animals, or other models to defined concentrations and monitor changes over specified periods. Observations may include biological, physiological, and pathological responses, allowing investigators to compare outcomes across exposure conditions and time points. This structured approach connects the administered substance with measurable effects and provides evidence for interpreting its safety profile.
Cells, tissues, animals, and other models each provide a setting for monitoring different types of responses to exposure. Across these systems, investigators can examine biological changes, physiological disturbances, or pathological findings. Using defined concentrations and observation periods helps relate model-specific results to possible target-organ injury, adverse drug reactions, and risks requiring further pharmacological evaluation.
Results can support candidate selection, dose optimization, risk assessment, and regulatory decisions. Evidence of harmful effects may influence whether a drug candidate advances or how its exposure is adjusted, while observations from repeated or chronic studies can clarify longer-term concerns. These findings also improve the safety assessment and interpretation of medicines considered for research and clinical practice.